Sorrento Therapeutics Buys Concortis Biosystems
socalTECH
NOVEMBER 14, 2013
San Diego-based Sorrento Therapeutics announced this morning that it is acquiring fellow, San Diego biotech Concortis Biosystems , to bolster its library of antibodies. As part of the acquisition, David (Zhenwei) Miao, PhD, Co-Founder, President and CSO of Concortis, will become Chief Technology Officer at Sorrento.
Let's personalize your content